Bank of New York Mellon
TLSI icon

Bank of New York Mellon’s TriSalus Life Sciences TLSI Stock Holding History

Bank of New York Mellon’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Buy
111,534
+45,730
+69% +$182K ﹤0.01% 3749
2026
Q1 		$263K Buy
65,804
+1,200
+2% +$5.88K ﹤0.01% 3907
2025
Q4 		$451K Buy
64,604
+17,900
+38% +$100K ﹤0.01% 3669
2025
Q3 		$217K Buy
46,704
+4,903
+12% +$23K ﹤0.01% 3978
2025
Q2 		$228K Buy
+41,801
New +$224K ﹤0.01% 3932

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bank of New York Mellon's TLSI Position: Q2 2026 in Review

Bank of New York Mellon increased its TriSalus Life Sciences (TLSI) stake by 69% in Q2 2026, buying an estimated $182K and bringing the position to 111,534 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

Bank of New York Mellon first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 34 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Bank of New York Mellon held 111,534 shares of TriSalus Life Sciences worth $507K as of Q2 2026.
  • Bank of New York Mellon bought 45,730 TriSalus Life Sciences shares in Q2 2026, an estimated $182K.
  • TriSalus Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3749 holding.
  • Bank of New York Mellon first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 34 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.